Advertisement
Advertisement

SIGA

SIGA logo

SIGA Technologies Inc.

3.04
USD
Sponsored
+0.10
+3.40%
Aug 25, 15:58 UTC -4
Closed
exchange

After-Market

3.09

+0.05
+1.61%

SIGA Technologies Inc. Profile

About

SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.

Info & Links

CEO

Diem Nguyen

Headquarters

31 EAST 62ND STREET
NEW YORK, NY 10065, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.siga.com

Auditor

PricewaterhouseCoopers LLP

Share holders

29

Employees

49

SIGA Technologies Inc. Statistics

Valuation Measures

Market Capitalization2

221.94M

Enterprise Value

104.36M

Enterprise Value/EBITDA(ttm)

-9.89

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.07

Price to Book(mrq)

1.32

Price to Cash(ytd)

9.13

Profitability

Gross Margin(ttm)

48.25%

Operating Margin(ttm)

-5.19%

Profit Margin(ttm)

-102.76%

Return on Equity(ttm)

-1.55%

Return on Invested Capital(ttm)

-0.60%

Return on Assets(ttm)

-1.32%

Income Statement

Revenue(ttm)

53.66M

Revenue Per Share(ttm)

0.75

Gross Profit(ttm)

29.17M

EBITDA(ttm)3

-10.55M

Net Income Available to Common(ttm)

-2.79M

Diluted EPS(ttm)

-0.05

Share Statistics

Beta (5Y Monthly)

0.97

52-Week Change

-66.70%

S&P 500 52-Week Change

19.04%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

71.85M

Dividend Yield

0.00%

Float4

69.89M

% Held by Insiders

2.73%

% Held by Institutions

55.40%

Balance Sheet

Total Cash(mrq)

117.58M

Total Cash Per Share(mrq)

1.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

21.72%

Quick Ratio(mrq)

16.48%

Book Value Per Share(mrq)

2.30

Cash Flow

Operating Cash Flow Per Share(ytd)

0.09

Free Cash Flow(ytd)

6.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement